FDA issues warning to 3+ major pharma firms for safety violations by 2028

Regulatory rollbacks under Trump will lead to increased scrutiny of safety protocols in the long term, as oversight gaps emerge. This will trigger enforcement actions against multiple pharmaceutical companies for compliance failures.

Implied probability (Yes)

70%